Otsuka Australia Pharmaceutical Pty Ltd
2 clinical trials · Sponsor
◉ Watch Otsuka Australia Pharmaceutical Pty Ltd
| Record | Firm | Date |
|---|---|---|
| A Study Comparing Treatment Preference Between Oral Decitabine/Cedazuridine and Azacitidine in Myelodysplastic Syndrome, Low-Blast Acute Myeloid Leukemia, or Chronic Myelomonocytic Leukemia (NCT05883956) | Otsuka Australia Pharmaceutical Pty Ltd | 2023-12-20 |
| Refine and Assess the Readability of Patient, Carer, and Clinician Treatment Preference in Myelodysplasia Questionnaire (NCT05817331) | Otsuka Australia Pharmaceutical Pty Ltd | 2022-06-28 |
Track Otsuka Australia Pharmaceutical Pty Ltd automatically
Every clearance here is in the API, with alerts when new ones post.